Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS-CoV-2 infection. [PDF]
Clin Transl Discov, 2022 Acharya A, Kutateladze TG, Byrareddy SN.
europepmc +1 more source
HIV-associated multi-centric Castleman’s disease with multiple organ failure: cuccessful treatment with rituximab [PDF]
, 2010 Introduction: Multicentric Castleman's Disease (MCD), a lymphoproliferative disorder associated with Human Herpes Virus-8 (HHV-8) infection, is increasing in incidence amongst HIV patients.
Agarwal, B +7 more
core
BAP1 loss augments sensitivity to BET inhibitors in cancer cells. [PDF]
Acta Pharmacol Sin, 2022 Xu YY +10 more
europepmc +1 more source
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies. [PDF]
Mol Cancer Ther, 2022 Burmeister A +16 more
europepmc +1 more source
Discovery of Benzo[d]imidazole-6-sulfonamides as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain. [PDF]
ChemMedChem, 2022 Cipriano A +13 more
europepmc +1 more source
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells. [PDF]
Leukemia, 2023 Romine KA +12 more
europepmc +1 more source
EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma. [PDF]
Clin Transl Med, 2022 Deng G +9 more
europepmc +1 more source
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors. [PDF]
Metabolites, 2021 Flynn NR +8 more
europepmc +1 more source
Achieving clinical success with BET inhibitors as anti-cancer agents. [PDF]
Br J Cancer, 2021 Shorstova T, Foulkes WD, Witcher M.
europepmc +1 more source
Controlling pre-leukemic thymocyte self-renewal [PDF]
, 2014 Goossens, Steven +1 more
core +2 more sources